PARTICIPATION

Shareholders who wish to participate in the Annual General Meeting must:

- be entered in the share register maintained by Euroclear Sweden AB on Monday 18 May 2026,

- have notified the AGM of their intention to attend and any assistance to the AGM no later than Wednesday 20 May 2026.

REGISTRATION

Notification can be made by e-mail to ir@organoclick.com or by post to OrganoClick AB, Linjalvägen 9, 187 66 Täby, Sweden. Notification must state name, personal identity number/corporate identity number and daytime telephone number. Notification must also state assistants (but not more than two) who will participate in the general meeting. Shareholders who are represented by proxy must issue a dated and signed power of attorney for the proxy. The original power of attorney and, for legal entities, a certified copy of the certificate of registration, should be sent to the company well in advance of the meeting at the above postal address, but no later than 20 May 2026. The power of attorney is valid for a maximum of one year from the date of issue, however, the validity period of the power of attorney may be no more than five years from the date of issuance if this is specifically stated. A proxy form is available on the company's website, www.organoclick.com.

Shareholders with nominee-registered shares must temporarily re-register their shares in their own name in order to be entitled to participate in the Annual General Meeting. Such registration must be effected at Euroclear Sweden AB no later than 18 May 2026. Contact should therefore be made with the nominee well in advance of this date.

Draft agenda

1. Opening of the meeting

2. Election of Chairman of the Meeting

The Nomination Committee's proposals: See below

3. Preparation and approval of the voting list

4. Election of one or two persons to verify the minutes

5. Approval of the agenda

6. Determination of whether the meeting has been duly convened

7. Speech by the CEO and questions from the shareholders to the company's Board of Directors and management

8. Presentation of the Annual Report and the Auditor's Report as well as the Consolidated Financial Statements and the Auditor's Report on the Group

9. Resolution on adoption of the income statement and balance sheet and the consolidated income statement and consolidated balance sheet

The Board of Directors' proposal: The income statements and balance sheets are adopted

10. Resolution on appropriation of the company's profit or loss in accordance with the adopted balance sheet

The Board's proposal: See below

11. Resolution on discharge from liability towards the company for the members of the Board of Directors and the CEO

12. Determination of the number of Board members, any deputies and auditors.

The Nomination Committee's proposals: See below

13. Determination of fees for Board assignments and fees to the company's auditor

The Nomination Committee's proposals: See below

14. Election of members of the Board of Directors and Chairman of the Board of Directors

The Nomination Committee's proposals: See below

15. Election of auditors

The Nomination Committee's proposals: See below

16. Nomination procedure and appointment of the Nomination Committee

The Nomination Committee's proposals: See below

17. Resolution on issue authorization to the Board of Directors

The Board's proposal: See below

18. Resolution on proposal for payment of remuneration to the Board of Directors in the form of shares in the company

The Nomination Committee's and major shareholders' proposals: See below

19. Any other business

20. Closing of the Meeting

Proposal for a decision

Item 2: Election of Chairman of the Meeting The Nomination Committee proposes that OrganoClick AB's Chairman Johan Magnusson be elected Chairman of the Annual General Meeting.

Item 10: Resolution on appropriation of the company's profit or loss
The Board of Directors and the CEO propose that the parent company's standing earnings of SEK 25,765,308 be carried forward.

Item 12: Determination of the number of Board members

The Nomination Committee proposes that the Board of Directors shall consist of four ordinary Board members, no deputies and one registered accounting firm as auditor.

Item 13: Determination of fees for Board assignments and fees to the company's auditor

The Nomination Committee proposes that the Chairman of the Board of Directors shall receive a fee of SEK 400,000 while the other ordinary members shall receive a fee of SEK 150,000 each.

It is proposed that fees to the auditor be paid for work performed in accordance with approved invoices.

Item 14: Election of members of the Board of Directors and Chairman of the Board of Directors

The Nomination Committee proposes re-election of the current ordinary members Charlotte Karlberg (member since 2020), Chatarina Schneider (member since 2023), Johan Magnusson (member since 2024) and Sara Lindell (member since 2025) and new election of Stefan Wahlén as a new member.

Håkan Gustavson, who has been a member since 2016, has declined re-election. We extend a big thank you to Håkan Gustavson for his contribution to the Board and OrganoClick's development during his time as a Board member.

Information about the Board members proposed for re-election is available on the Company's website https://organoclick.com/sv/styrelse.

Stefan Wahlén

Year of birth: 1959

Selected historical assignments: CEO of Patagonia Europe, Global Sales Manager for Peak Performance and VP International Development & Sales at Wolsey Limited. Stefan is independent of the company's major shareholders.

The Nomination Committee proposes re-election of Johan Magnusson as Chairman of the Board.

Item 15: Election of auditor
The Nomination Committee proposes re-election of the registered accounting firm BDO Mälardalen AB, with auditor in charge Emilie Sleth, for a term of office of one year and extending until the end of the next Annual General Meeting.

Item 16: Nomination procedure and appointment of the Nomination Committee

The Nomination Committee proposes that the Annual General Meeting instruct the Chairman of the Board to contact the three largest shareholders according to Euroclear Sweden AB's transcript of the share register as of 30 September 2026, each of which will appoint one member of the Nomination Committee. A representative of the largest shareholders shall be appointed as Chairman of the Nomination Committee. In addition, the members of the Nomination Committee shall have the right to co-opt the Chairman of the Board to the Nomination Committee if deemed desirable. If any of the three largest shareholders waives its right to appoint a member to the Nomination Committee, the next shareholder in size shall be given the opportunity to appoint a member to the Nomination Committee. In the event of a change in ownership at the end of the fourth quarter, the composition of the Nomination Committee shall, if possible and if deemed necessary, be adapted to the new ownership structure.

Ahead of the 2027 Annual General Meeting, the Nomination Committee shall prepare proposals for (i) the Chairman of the Annual General Meeting, (ii) election of the Board of Directors, (iii) election of the Chairman of the Board, (iv) election of auditor, (v) remuneration of the Board of Directors and auditor, and (vi) criteria for the appointment of the Nomination Committee.

No fees shall be paid to the members of the Nomination Committee. The Nomination Committee shall be entitled, with the approval of the Chairman of the Board, to charge the company with costs for, for example, recruitment consultants or other costs required for the Nomination Committee to be able to fulfill its assignment.

Item 17: Resolution on issue authorization to the Board of Directors
The Board of Directors proposes that the Board of Directors be authorized, until the next Annual General Meeting, on one or more occasions to resolve on the issue of shares, warrants or convertibles, with or without preferential rights for the shareholders to be paid in cash, in kind or by set-off. The issue may entail a total increase in the share capital by a maximum of 10% or SEK 110,003 (corresponding to 11,000,302 shares).

Such an issue may entail deviation from the shareholders' preferential rights to subscribe for new shares. In the event of deviation from the shareholders' preferential rights, the basis for the issue price shall be market terms. The Board of Directors further proposes that the Annual General Meeting authorizes the Board of Directors, or a person appointed by the Board of Directors, to make such minor adjustments to the resolution above as may prove necessary in connection with the registration with the Swedish Companies Registration Office.

Item 18: Resolution on proposal for payment of remuneration to the Board of Directors in the form of shares in the company

The Nomination Committee's proposal is that the Board members of the Company shall have the right to choose whether the Board fees shall be paid in shares in the Company or in cash. In order to enable payment of fees to the Board members who have chosen to receive remuneration in the form of shares, major shareholders propose that the Annual General Meeting resolves on a directed issue of a maximum of 749,038 shares, corresponding to a value of a maximum of SEK 584,250, with deviation from the shareholders' preferential rights. This corresponds to an increase in the share capital of a maximum of SEK 7490.38, which gives a dilution effect for existing shareholders of 0.68%. For the Directed Issue, the following terms and conditions shall otherwise apply.

Right to subscribe for new shares
The right to subscribe for new shares shall, with deviation from the shareholders' preferential rights, be granted to members of the Board of Directors of the Company who have chosen to receive remuneration in the form of shares, whereby a total of five persons may receive allotment. The reason for the deviation from the shareholders' preferential rights is to enable the Company to fulfil its obligations regarding payment of remuneration to the Board of Directors in the form of shares.

Subscription course
The subscription price is set at SEK 0.78 per share, calculated as the average volume-weighted share price (VWAP) during the last 10 trading days prior to the publication of the notice (2026-04-21) on Nasdaq First North Growth Market and is assessed by major shareholders to be in line with market conditions. The amount that constitutes the premium shall be added to the unrestricted share premium reserve.

Subscription and payment
Subscription of the newly issued shares shall take place no later than 2 June 2026. Payment for subscribed shares shall be made in connection with subscription by set-off of the receivable. The Board of Directors has the right to extend the subscription period and the time for payment.

Right to dividends
The new shares entitle to dividend for the first time on the record date for dividend that occurs immediately after the new shares have been registered with the Swedish Companies Registration Office and the shares have been entered in the share register maintained by Euroclear Sweden AB.

Other
Documents pursuant to Chapter 13. Sections 6-8 of the Swedish Companies Act have been prepared and are available at the Company.

The Board of Directors, the CEO or a person appointed by the Board of Directors shall be entitled to make such minor adjustments to the resolution as may prove necessary in connection with the registration thereof.

A valid resolution in accordance with this proposal requires that it is supported by shareholders holding at least nine-tenths (9/10) of both the votes cast and the shares represented at the Annual General Meeting.

.……………………….

Majority rules

A resolution in accordance with the Board of Directors' proposal under item 18 requires that the resolution is supported by shareholders representing at least two-thirds of both the votes cast and the shares represented at the Annual General Meeting.

Other

Complete proposals for resolutions, accounting documents, the auditor's report and other documents for the Annual General Meeting will be published on the company's website https://organoclick.com and will be available at the company's premises at Linjalvägen 9, SE-187 66 Täby no later than three weeks prior to the Annual General Meeting. The documents will be sent free of charge to shareholders who specifically request it and state their postal address.

The Board of Directors and the CEO shall, if any shareholder so requests and the Board of Directors considers that it can be done without material harm to the Company, provide information on circumstances that may affect the assessment of an item on the agenda and circumstances that may affect the assessment of the Company's or its subsidiaries' financial situation as well as the Company's relationship with other group companies. Anyone who wishes to submit questions may do so to ir@organoclick.com, or by post at the address stated above.

***

Welcome!
Stockholm, April 2026
The Board of Directors

For more information, please contact:
Mårten Hellberg, CEO
+46 8 684 001 10
marten.hellberg@organoclick.com